Catalyst
Slingshot members are tracking this event:
Sage Receives FDA Breakthrough Therapy Designation for SAGE-547 for the Treatment of Postpartum Depression
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| SAGE |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 06, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Breakthrough Therapy Designation, Sage-547, Postpartum Depression
